People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ingenia Therapeutics Inc. | — | Biotechnology | Series A | $16.8M | $26.9M | 2024 |
Sang Gyun Kim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sang Gyun Kim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eric Furfine | 1 | 3 |
| Joo Hee Kwak | 1 | 1 |
| Sangyeul Han | 1 | 1 |
| Kwang Ho Cheong | 1 | 1 |
| Sung Jae Kim | 1 | 1 |
| Heewon Park | 1 | 1 |
| Minji Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.